Mojgan Mortazavi
Isfahan University of Medical Sciences
109 Papers
340 Citations
Mojgan Mortazavi is an academic researcher from Isfahan University of Medical Sciences. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 16, co-authored 83 publications. Previous affiliations of Mojgan Mortazavi include University of Isfahan & University of Bristol.
Chat about Author
Papers
Effect of Magnesium Supplementation on Carotid Intima-Media Thickness and Flow-Mediated Dilatation among Hemodialysis Patients: A Double-Blind, Randomized, Placebo-Controlled Trial
Mojgan Mortazavi,Firouzeh Moeinzadeh,Mohammad Saadatnia,Shahrzad Shahidi,Jeanie McGee,Alireza Minagar +5 more
TL;DR: The results indicate that Mg might not improve endothelial function (CRP level and FMD) and that a decreased cIMT as a marker of atherosclerosis may be due to the inhibition of calcification through the regulation parathormone, calcium, and phosphorus.
90
Aerobic Exercise Improves Signs of Restless Leg Syndrome in End Stage Renal Disease Patients Suffering Chronic Hemodialysis
Mojgan Mortazavi,Babak Vahdatpour,Aida Ghasempour,Diana Taheri,Shahrzad Shahidi,Firouzeh Moeinzadeh,Bahareh Dolatkhah,Shahaboddin Dolatkhah +7 more
TL;DR: Using aerobic exercise for improving signs of restless leg syndrome is suggested, but no evidence was found for its efficacy on patient's quality of life.
Oxford-MEST classification in IgA nephropathy patients: A report from Iran
Hamid Nasri,Mojgan Mortazavi,Ali Ghorbani,Heshmatollah Shahbazian,Soleiman Kheiri,Azar Baradaran,Afsoon Emami-Naieni,Maryam Saffari,Saeed Mardani,Ali Momeni,Yahya Madihi,Milad Baradaran-Ghahfarokhi,Mahmoud Rafieian-Kopaie,Parin Hedayati,Shahzad Baradaran,Mohammadreza Ardalan,Shahram Sajjadieh,Naziheh Assarzadegan,Seyed Mohammad Ahmadi Soleimani,Mohamad Reza Tamadon +19 more
TL;DR: Higher prevalence of segmental glomerulosclerosis and interstitial fibrosis/ tubular atrophy, as the two of, four variables of Oxford-MEST classification of IgAN in male patients further attests that male gender is a risk factor in this disease.
61
Effects of Oral L-Carnitine Supplementation on Lipid Profile, Anemia, and Quality of Life in Chronic Renal Disease Patients under Hemodialysis: A Randomized, Double-Blinded, Placebo-Controlled Trial.
Afsoon Emami Naini,Mahnaz Moradi,Mojgan Mortazavi,Asghar Amini Harandi,Mehdi Hadizadeh,Farhad Shirani,Hamed Basir Ghafoori,Pardis Emami Naini +7 more
TL;DR: In ESRD patients under maintenance hemodialysis, oral L-carnitine supplementation may reduce triglyceride and cholesterol and increase HDL and hemoglobin and subsequently reduce needed erythropoietin dose without effect on QOL.
Granulomatosis with polyangiitis (Wegener's) presenting as the right ventricular masses: A case report and review of the literature.
Mojgan Mortazavi,Hamid Nasri +1 more
TL;DR: Presence of three small masses in right ventricular cavity and pulmonary artery hypertension in association with the spleen lesions were an uncommon presentation of GPA, which should be considered in the differential diagnosis of any nonspecific illnesses with cardiac involvement.
44